384 related articles for article (PubMed ID: 32145592)
1. Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor.
Pierce ML; French JA; Murray TF
Biomed Pharmacother; 2020 Jun; 126():110060. PubMed ID: 32145592
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the pharmacologic profiles of arginine vasopressin and oxytocin analogs at marmoset, titi monkey, macaque, and human oxytocin receptors.
Pierce ML; French JA; Murray TF
Biomed Pharmacother; 2020 May; 125():109832. PubMed ID: 32018219
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of the Ability of Leu
Pierce ML; Mehrotra S; Mustoe AC; French JA; Murray TF
Mol Pharmacol; 2019 Apr; 95(4):376-385. PubMed ID: 30739093
[TBL] [Abstract][Full Text] [Related]
4. Binding Characteristics of Two Oxytocin Variants and Vasopressin at Oxytocin Receptors from Four Primate Species with Different Social Behavior Patterns.
Taylor JH; Schulte NA; French JA; Toews ML
J Pharmacol Exp Ther; 2018 Oct; 367(1):101-107. PubMed ID: 30068728
[TBL] [Abstract][Full Text] [Related]
5. Leu
Mustoe A; Schulte NA; Taylor JH; French JA; Toews ML
Sci Rep; 2019 Oct; 9(1):15480. PubMed ID: 31664130
[TBL] [Abstract][Full Text] [Related]
6. Binding affinities of oxytocin, vasopressin and Manning compound at oxytocin and V1a receptors in male Syrian hamster brains.
Taylor JH; McCann KE; Ross AP; Albers HE
J Neuroendocrinol; 2020 Jul; 32(7):e12882. PubMed ID: 32662552
[TBL] [Abstract][Full Text] [Related]
7. Molecular pharmacology of human vasopressin receptors.
Thibonnier M; Conarty DM; Preston JA; Wilkins PL; Berti-Mattera LN; Mattera R
Adv Exp Med Biol; 1998; 449():251-76. PubMed ID: 10026814
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin (OT) and arginine-vasopressin (AVP) act on OT receptors and not AVP V1a receptors to enhance social recognition in adult Syrian hamsters (Mesocricetus auratus).
Song Z; Larkin TE; Malley MO; Albers HE
Horm Behav; 2016 May; 81():20-7. PubMed ID: 26975586
[TBL] [Abstract][Full Text] [Related]
9. Activation of oxytocin receptors, but not arginine-vasopressin V1a receptors, in the ventral tegmental area of male Syrian hamsters is essential for the reward-like properties of social interactions.
Song Z; Borland JM; Larkin TE; O'Malley M; Albers HE
Psychoneuroendocrinology; 2016 Dec; 74():164-172. PubMed ID: 27632574
[TBL] [Abstract][Full Text] [Related]
10. Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells.
Tsukada J; Tahara A; Tomura Y; Wada Ki ; Kusayama T; Ishii N; Yatsu T; Uchida W; Taniguchi N; Tanaka A
Br J Pharmacol; 2001 Jul; 133(5):746-54. PubMed ID: 11429400
[TBL] [Abstract][Full Text] [Related]
11. Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors.
Yibchok-anun S; Hsu WH
Life Sci; 1998; 63(21):1871-8. PubMed ID: 9825765
[TBL] [Abstract][Full Text] [Related]
12. Place preferences associated with pups or cocaine change the expression of D2R, V1aR and OTR in the NAcc and MeA and the levels of plasma AVP, OT, T and E2 in mandarin vole fathers.
Fang Q; Wang J
Psychoneuroendocrinology; 2017 Jun; 80():147-154. PubMed ID: 28371737
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery.
Song Z; Albers HE
Front Neuroendocrinol; 2018 Oct; 51():14-24. PubMed ID: 29054552
[TBL] [Abstract][Full Text] [Related]
14. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
[TBL] [Abstract][Full Text] [Related]
15. Relationships among estrogen receptor, oxytocin and vasopressin gene expression and social interaction in male mice.
Murakami G; Hunter RG; Fontaine C; Ribeiro A; Pfaff D
Eur J Neurosci; 2011 Aug; 34(3):469-77. PubMed ID: 21749489
[TBL] [Abstract][Full Text] [Related]
16. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.
Postina R; Kojro E; Fahrenholz F
Adv Exp Med Biol; 1998; 449():371-85. PubMed ID: 10026828
[TBL] [Abstract][Full Text] [Related]
17. Structures of the arginine-vasopressin and oxytocin receptor signaling complexes.
Bous J; Fouillen A; Orcel H; Granier S; Bron P; Mouillac B
Vitam Horm; 2023; 123():67-107. PubMed ID: 37718002
[TBL] [Abstract][Full Text] [Related]
18. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
[TBL] [Abstract][Full Text] [Related]
19. Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors.
Busnelli M; Bulgheroni E; Manning M; Kleinau G; Chini B
J Pharmacol Exp Ther; 2013 Aug; 346(2):318-27. PubMed ID: 23723434
[TBL] [Abstract][Full Text] [Related]
20. Distribution of vasopressin and oxytocin binding sites in the brain and upper spinal cord of the common marmoset.
Schorscher-Petcu A; Dupré A; Tribollet E
Neurosci Lett; 2009 Sep; 461(3):217-22. PubMed ID: 19539696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
